CH Biomedical is trialing the world’s smallest “artificial heart” that may one day replace heart transplants, providing lifelong therapy to treat advanced heart failure.
Why
Lack of heart donors
Suitable donors for heart transplant are hard to find.
Expensive heart treatments
More affordable artificial hearts and other medical devices needed to help more patients.
Market
$3.5bn
Projected global market value of ventricular assist devices by 2025, growing at 6.3% CAGR from $2.2bn in 2018, according to Global Market Insights.
The rest of the content is only available if you are logged in.
